{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:19:43Z","timestamp":1772774383699,"version":"3.50.1"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007088","name":"Uniwersytet Jagiello\u0144ski w Krakowie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbrc.2025.152410","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T22:59:06Z","timestamp":1753484346000},"page":"152410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Role of the orexin system in modulating the tumor microenvironment: implications for tumor progression and cancer therapy"],"prefix":"10.1016","volume":"778","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5033-4415","authenticated-orcid":false,"given":"Monika","family":"\u017buwa\u0142a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5580-3896","authenticated-orcid":false,"given":"Marcelina","family":"Janik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1461-9392","authenticated-orcid":false,"given":"Marian","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152410_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107993","article-title":"The hypocretin (orexin) system: from a neural circuitry perspective","volume":"167","author":"Li","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbrc.2025.152410_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.regpep.2004.08.006","article-title":"Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology","volume":"126","author":"Sakurai","year":"2005","journal-title":"Regul. Pept."},{"key":"10.1016\/j.bbrc.2025.152410_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2741\/1074","article-title":"Arousal systems","volume":"8","author":"Jones","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbrc.2025.152410_bib4","first-page":"179","article-title":"Projekcja oreksynowa (hipokretynowa) nowym uk\u0142adem niespecyficznym m\u00f3zgowia ssak\u00f3w, Acta Universitatis Lodziensis","volume":"3","author":"Lewandowski","year":"2006","journal-title":"Folia Biol. Oecol."},{"key":"10.1016\/j.bbrc.2025.152410_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.931970","article-title":"The Orexin receptors: structural and anti-tumoral properties","volume":"13","author":"Couvineau","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2025.152410_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-642-24716-3_4","article-title":"Neuropeptides controlling energy balance: orexins and neuromedins","volume":"209","author":"Nixon","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152410_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2023.171009","article-title":"Internal and external modulation factors of the orexin system","volume":"165","author":"Maruyama","year":"2023","journal-title":"Peptides"},{"key":"10.1016\/j.bbrc.2025.152410_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12079-022-00700-3","article-title":"A molecular network map of orexin-orexin receptor signaling system","volume":"17","author":"Chatterjee","year":"2023","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.bbrc.2025.152410_bib9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.tem.2023.02.008","article-title":"Regulatory effect of orexin system on various diseases through mTOR signaling pathway","volume":"34","author":"Song","year":"2023","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2025.152410_bib10","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/bph.17422","article-title":"Pharmacodynamics of the orexin type 1 (OX1) receptor in colon cancer cell models: a two-sided nature of antagonistic ligands resulting from partial dissociation of Gq","volume":"182","author":"Gratio","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152410_bib11","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.cellsig.2008.05.010","article-title":"The signalling profile of recombinant human orexin-2 receptor, Cell","volume":"20","author":"Tang","year":"2008","journal-title":"Signal"},{"key":"10.1016\/j.bbrc.2025.152410_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1677\/JOE-08-0536","article-title":"Orexin-stimulated MAP kinase cascades are activated through multiple G-protein signalling pathways in human H295R adrenocortical cells: diverse roles for orexins A and B","volume":"202","author":"Ramanjaneya","year":"2009","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbrc.2025.152410_bib13","article-title":"Orexin A affects INS-1 rat insulinoma cell proliferation via orexin receptor 1 and the AKT signaling pathway","volume":"2013","author":"Chen","year":"2013","journal-title":"Internet J. Endocrinol."},{"key":"10.1016\/j.bbrc.2025.152410_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3892\/ijmm.2014.1769","article-title":"Orexin A protects cells from apoptosis by regulating FoxO1 and mTORC1 through the OX1R\/PI3K\/AKT signaling pathway in hepatocytes","volume":"34","author":"Ju","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbrc.2025.152410_bib15","doi-asserted-by":"crossref","first-page":"45875","DOI":"10.1074\/jbc.M404136200","article-title":"Orexins acting at native OX(1) receptor in colon cancer and neuroblastoma cells or at recombinant OX(1) receptor suppress cell growth by inducing apoptosis","volume":"279","author":"Rouet-Benzineb","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.152410_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1113\/JP280275","article-title":"Circadian actions of orexins on the retinorecipient lateral geniculate complex in rat","volume":"599","author":"Chrobok","year":"2020","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbrc.2025.152410_bib17","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s12276-021-00681-0","article-title":"Roles of circadian clocks in cancer pathogenesis and treatment","volume":"53","author":"Lee","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbrc.2025.152410_bib18","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.tcb.2021.06.008","article-title":"Circadian regulation of cancer cell and tumor microenvironment crosstalk","volume":"31","author":"Xuan","year":"2021","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbrc.2025.152410_bib19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/cells13020138","article-title":"Circadian rhythms, chrononutrition, physical training, and redox homeostasis-molecular mechanisms in human health","volume":"13","author":"Dr\u0103goi","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2025.152410_bib20","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1242\/jcs.03174","article-title":"Circadian oscillators of Drosophila and mammals","volume":"119","author":"Yu","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbrc.2025.152410_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neuroscience.2019.10.002","article-title":"Diurnal regulation of the orexin\/hypocretin system in mice","volume":"421","author":"Ventzke","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2025.152410_bib22","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1523\/JNEUROSCI.3388-13.2014","article-title":"Acute suppressive and long-term phase modulation actions of orexin on the mammalian circadian clock","volume":"34","author":"Belle","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2025.152410_bib23","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1177\/0271678X221082786","article-title":"Choroid plexus function in neurological homeostasis and disorders: the awakening of the circadian clocks and orexins","volume":"42","author":"Christensen","year":"2002","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.bbrc.2025.152410_bib24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.trecan.2019.07.002","article-title":"Interplay between circadian clock and cancer: new frontiers for cancer treatment","volume":"5","author":"Sulli","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbrc.2025.152410_bib25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41386-024-02017-8","article-title":"Orexinergic modulation of chronic jet lag-induced deficits in mouse cognitive flexibility","volume":"50","author":"Duske","year":"2025","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbrc.2025.152410_bib26","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1158\/2159-8290.CD-20-0413","article-title":"Cancer in the Fourth Dimension: what is the impact of circadian disruption?","volume":"10","author":"Pariollaud","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbrc.2025.152410_bib27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/iju.14231","article-title":"Circadian clock and cancer: from a viewpoint of cellular differentiation","volume":"27","author":"Tsuchiya","year":"2020","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.bbrc.2025.152410_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/gtc.12552","article-title":"Disruption of circadian clockwork in in vivo reprogramming-induced mouse kidney tumors","volume":"23","author":"Ohashi","year":"2018","journal-title":"Genes Cells"},{"key":"10.1016\/j.bbrc.2025.152410_bib29","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1080\/15384101.2019.1648957","article-title":"Circadian oscillations persist in low malignancy breast cancer cells","volume":"18","author":"Lellupitiyage Don","year":"2019","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbrc.2025.152410_bib30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2025.152410_bib31","series-title":"Bioactive Components, Diet and Medical Treatment in Cancer Prevention","first-page":"1","article-title":"Risk factors for cancer: genetic and environment","author":"Rahman","year":"2018"},{"key":"10.1016\/j.bbrc.2025.152410_bib32","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2025.152410_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4137\/CGM.S11285","article-title":"Regulation of tumor growth and metastasis: the role of tumor microenvironment","volume":"7","author":"Goubran","year":"2014","journal-title":"Cancer Growth Metastasis"},{"key":"10.1016\/j.bbrc.2025.152410_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1118637","article-title":"Neurotransmitters: promising immune modulators in the tumor microenvironment","volume":"14","author":"Xiao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.152410_bib35","doi-asserted-by":"crossref","first-page":"485","DOI":"10.5604\/01.3001.0010.3830","article-title":"Stress and its molecular consequences in cancer progression","volume":"71","author":"Surman","year":"2017","journal-title":"Postep. Hig. Med. Dosw. (Online)."},{"key":"10.1016\/j.bbrc.2025.152410_bib36","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1002\/1873-3468.14017","article-title":"G Protein-Coupled Receptors and heterotrimeric G proteins as cancer drivers","volume":"594","author":"Arang","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2025.152410_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nature12688","article-title":"A melanocyte lineage program confers resistance to MAP kinase pathway inhibition","volume":"504","author":"Johannessen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.152410_bib38","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.3390\/molecules26164849","article-title":"Orexins\/hypocretins and cancer: a neuropeptide as emerging target","volume":"26","author":"Alain","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2025.152410_bib39","article-title":"Multiomics integration reveals the effect of Orexin A on glioblastoma","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152410_bib40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3389\/fendo.2018.00647","article-title":"The orexin-A-regulated Akt\/mTOR pathway promotes cell proliferation through inhibiting apoptosis in pancreatic cancer cells","volume":"9","author":"Suo","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2025.152410_bib41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3892\/ijmm.2010.590","article-title":"Elevated expression of orexin receptor 2 (HCRTR2) in benign prostatic hyperplasia is accompanied by lowered serum orexin A concentrations","volume":"27","author":"Malendowicz","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbrc.2025.152410_bib42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3892\/ol.2011.528","article-title":"Orexin 2 receptor as a potential target for immunotoxin and antibody-drug conjugate cancer therapy","volume":"3","author":"Kishida","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrc.2025.152410_bib43","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.gastrohep.2019.10.006","article-title":"Orexin A associates with inflammation by interacting with OX1R\/OX2R receptor and activating prepro-Orexin in cancer tissues of gastric cancer patients","volume":"43","author":"Hu","year":"2020","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2025.152410_bib44","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1210\/jc.2012-3263","article-title":"Expression of type 2 orexin receptor in human endometrium and its epigenetic silencing in endometrial cancer","volume":"98","author":"Dehan","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2025.152410_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1336145","article-title":"Orexins in apoptosis: a dual regulatory role","volume":"18","author":"Cavalu","year":"2024","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbrc.2025.152410_bib46","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbrc.2025.152410_bib47","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/febs.17312","article-title":"Obesity, white adipose tissue and cancer","volume":"292","author":"Solsona-Vilarrasa","year":"2025","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2025.152410_bib48","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3389\/fphys.2018.00982","article-title":"Adiponectin and Orexin-A as a potential immunity link between adipose tissue and central nervous system","volume":"9","author":"Polito","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbrc.2025.152410_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1677\/joe.1.06886","article-title":"Orexin receptor expression in human adipose tissue: effects of orexin-A and orexin-B","volume":"191","author":"Digby","year":"2006","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbrc.2025.152410_bib50","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00424-019-02318-8","article-title":"Orexin A-induced inhibition of leptin expression and secretion in adipocytes reducing plasma leptin levels and hypothalamic leptin resistance","volume":"471","author":"Shin","year":"2019","journal-title":"Pflugers Arch. - Eur. J. Physiol."},{"key":"10.1016\/j.bbrc.2025.152410_bib51","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.3390\/ijms22062870","article-title":"Leptin and cancer: updated functional roles in carcinogenesis, therapeutic niches, and developments","volume":"22","author":"Lin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152410_bib52","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1515\/mr-2022-0017","article-title":"Leptin signaling and leptin resistance","volume":"2","author":"Liu","year":"2022","journal-title":"Medical Review."},{"key":"10.1016\/j.bbrc.2025.152410_bib53","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.pbb.2010.06.013","article-title":"Increased orexin and melanin-concentrating hormone expression in the perifornical lateral hypothalamus of rats prone to overconsuming a fat-rich diet","volume":"96","author":"Morganstern","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2025.152410_bib54","first-page":"13","article-title":"Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome","volume":"58","author":"Zwirska-Korczala","year":"2007","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152410_bib55","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00125-011-2152-2","article-title":"Orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion from 3T3-L1 adipocytes and isolated primary rat adipocytes","volume":"54","author":"Skrzypski","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2025.152410_bib56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12974-019-1447-y","article-title":"Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation","volume":"16","author":"Becquet","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbrc.2025.152410_bib57","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/STROKEAHA.112.681700","article-title":"Mitigation of murine focal cerebral ischemia by the hypocretin\/orexin system is associated with reduced inflammation","volume":"44","author":"Xiong","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.bbrc.2025.152410_bib58","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10517-023-05770-w","article-title":"Morphofunctional features of microglial cells during the administration of orexin A","volume":"174","author":"Synchikova","year":"2023","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.bbrc.2025.152410_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111018","article-title":"Orexin A alleviates LPS-induced acute lung injury by inhibiting macrophage activation through JNK-mediated autophagy","volume":"124","author":"Nie","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbrc.2025.152410_bib60","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/nu12010053","article-title":"Orexin-A exerts equivocal role in atherosclerosis process depending on the duration of exposure: in vitro study","volume":"12","author":"Nasiri Ansari","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bbrc.2025.152410_bib61","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/iub.1890","article-title":"Orexin A suppresses oxidized ldl induced endothelial cell inflammation via MAPK p38 and NF-\u03baB signaling pathway","volume":"70","author":"Zhang","year":"2018","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbrc.2025.152410_bib62","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-019-0580-3","article-title":"Active roles of dysfunctional vascular endothelium in fibrosis and cancer","volume":"26","author":"Hsu","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbrc.2025.152410_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1367875","article-title":"Endothelial cells in tumor microenvironment: insights and perspectives","volume":"15","author":"Leone","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.152410_bib64","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.trecan.2020.03.002","article-title":"Exosomal PD-L1: roles in tumor progression and immunotherapy","volume":"6","author":"Morrissey","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbrc.2025.152410_bib65","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s10620-021-07077-0","article-title":"Orexin A suppresses the expression of exosomal PD-L1 in colon cancer and promotes T cell activity by inhibiting JAK2\/STAT3 signaling pathway","volume":"67","author":"Wen","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbrc.2025.152410_bib66","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3390\/brainsci11081098","article-title":"Role of vitamin E and the orexin system in neuroprotection","volume":"11","author":"La Torre","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.bbrc.2025.152410_bib67","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1080\/21691401.2019.1614014","article-title":"Orexin A ameliorates HBV X protein-induced cytotoxicity and inflammatory response in human hepatocytes","volume":"47","author":"Wang","year":"2019","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.bbrc.2025.152410_bib68","doi-asserted-by":"crossref","DOI":"10.1177\/2058738418785739","article-title":"Orexin-A protects SH-SY5Y cells against H2O2-induced oxidative damage via the PI3K\/MEK1\/2\/ERK1\/2 signaling pathway","volume":"32","author":"Wang","year":"2018","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152410_bib69","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cell.2018.05.009","article-title":"Acid suspends the circadian clock in hypoxia through inhibition of mTOR","volume":"174","author":"Walton","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2025.152410_bib70","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fonc.2018.00185","article-title":"Expression of the circadian clock gene BMAL1 positively correlates with antitumor immunity and patient survival in metastatic melanoma","volume":"8","author":"de Assis","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2025.152410_bib71","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12988","article-title":"Circadian clock genes promote glioma progression by affecting tumour immune infiltration and tumour cell proliferation","volume":"54","author":"Wang","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bbrc.2025.152410_bib72","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbi.2013.11.003","article-title":"A role for orexin in cytotoxic chemotherapy-induced fatigue","volume":"37","author":"Weymann","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbrc.2025.152410_bib73","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s12964-024-01857-7","article-title":"Chemoresistance and the tumor microenvironment: the critical role of cell \u2013 cell communication","volume":"22","author":"Wilczy\u0144ski","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbrc.2025.152410_bib74","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fendo.2019.00219","article-title":"Orexin-A prevents lipopolysaccharide-induced neuroinflammation at the level of the intestinal barrier","volume":"10","author":"Tunisi","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2025.152410_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104882","article-title":"Bidirectional gut-brain communication: a role for orexin-A","volume":"141","author":"Mediavilla","year":"2020","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbrc.2025.152410_bib76","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti\u2013PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2025.152410_bib77","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2025.152410_bib78","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2025.152410_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.904327","article-title":"The orexin-A\/OX1R system induces cell death in pancreatic cancer cells resistant to gemcitabine and Nab-paclitaxel treatment","volume":"12","author":"Voisin","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2025.152410_bib80","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1158\/0008-5472.CAN-10-3473","article-title":"Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis","volume":"71","author":"Voisin","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152410_bib81","author":"Chartrel","year":"2017"},{"key":"10.1016\/j.bbrc.2025.152410_bib82","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.ejca.2014.05.008","article-title":"The orexin type 1 receptor is overexpressed in advanced prostate cancer with a neuroendocrine differentiation, and mediates apoptosis","volume":"50","author":"Alexsandre","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbrc.2025.152410_bib83","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.3390\/cancers13112612","article-title":"Focus on the complex interconnection between cancer, narcolepsy and other neurodegenerative diseases: a possible case of orexin-dependent inverse comorbidity","volume":"13","author":"Mogavero","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25011258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25011258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:24:50Z","timestamp":1772771090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25011258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":83,"alternative-id":["S0006291X25011258"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152410","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the orexin system in modulating the tumor microenvironment: implications for tumor progression and cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152410"}}